0001493152-22-027052.txt : 20220928
0001493152-22-027052.hdr.sgml : 20220928
20220928163905
ACCESSION NUMBER: 0001493152-22-027052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220926
FILED AS OF DATE: 20220928
DATE AS OF CHANGE: 20220928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alland Leila
CENTRAL INDEX KEY: 0001825216
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15771
FILM NUMBER: 221276558
MAIL ADDRESS:
STREET 1: C/O PMV PHARMACEUTICALS, INC.
STREET 2: 8 CLARKE DRIVE, SUITE 3
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 646-813-4701
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2022-09-26
0
0000318306
ABEONA THERAPEUTICS INC.
ABEO
0001825216
Alland Leila
1330 AVENUE OF THE AMERICAS, 33RD FLOOR
NEW YORK
NY
10019
1
0
0
0
Common Stock
2022-09-26
4
A
0
13400
0
A
20414
D
All of the restricted stock will vest on September 26, 2023.
On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split.
/s/ Leila Alland
2022-09-28